A Mutation, in the Iron-Responsive Element of H Ferritin mRNA, Causing Autosomal Dominant Iron Overload  by Kato, Junji et al.
Am. J. Hum. Genet. 69:191–197, 2001
191
Report
A Mutation, in the Iron-Responsive Element of H Ferritin mRNA, Causing
Autosomal Dominant Iron Overload
Junji Kato,1 Koshi Fujikawa,1,2 Megumi Kanda,1,3 Nao Fukuda,1,3 Katsunori Sasaki,1,2
Tetsuji Takayama,1 Masayoshi Kobune,1,2 Kohichi Takada,1 Rishu Takimoto,1
Hirofumi Hamada,2 Tatsuru Ikeda,4 and Yoshiro Niitsu1
1Fourth Department of Internal Medicine and 2Department of Molecular Medicine, Sapporo Medical University School of Medicine, and
3Department of Clinical Pathology, Sapporo Medical University Hospital, Sapporo, Japan; and 4Laboratory of Drug Metabolism, Division
of Pharmacobio-Dynamics, Graduate School of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan
Ferritin, which is composed of H and L subunits, plays an important role in iron storage and in the control of
intracellular iron distribution. Synthesis of both ferritin subunits is controlled by a common cytosolic protein, iron
regulatory protein (IRP), which binds to the iron-responsive element (IRE) in the 5′-UTR of the H- and L-ferritin
mRNAs. In the present study, we have identified a single point mutation (A49U) in the IRE motif of H-ferritin
mRNA, in four of seven members of a Japanese family affected by dominantly inherited iron overload. Gel-shift
mobility assay and Scatchard-plot analysis revealed that a mutated IRE probe had a higher binding affinity to IRP
than did the wild-type probe. When mutated H subunit was overexpressed in COS-1 cells, suppression of H-subunit
synthesis and of the increment of radiolabeled iron uptake were observed. These data suggest that the A49U
mutation in the IRE of H-subunit is responsible for tissue iron deposition and is a novel cause of hereditary iron
overload, most likely related to impairment of the ferroxidase activity generated by H subunit.
In white populations, 190% of patients with primary
iron overload carry a characteristic mutation, C282Y/
H63D, in the hemochromatosis gene (HFE-1) (Feder et
al. 1996) or mutation Y250X in the transferrin receptor
2 gene (TFR2, or HFE-3) (Camaschella et al. 2000).
However, in Melanesians as well as in Africans and
Asians, the gene responsible for primary iron overload
is considered to be largely attributable to non-HFE al-
leles (Monaghan et al. 1998; Sohda et al. 1999).
Ferritin consists of H and L subunits, which assemble
to form a shell of 24 subunits with an iron core. Both
subunits play important roles in iron storage and in the
control of intracellular iron distribution (Theil 1987;
Santambrogio et al. 1992; Harrison and Arosio 1996),
and it has been shown that each has a distinct role in
cellular iron metabolism: H subunit generates ferroxi-
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dase activity that appears to be essential for incorpo-
ration of iron into the protein shell, whereas L subunit
facilitates iron-core formation (Harrison and Arosio
1996). Although H subunit and L subunit are encoded
by different genes, located on 11q13 and 19q13.1, re-
spectively (McGill et al. 1987), synthesis of both sub-
units is controlled by a common cytosolic protein, iron
regulatory protein (IRP), which binds to the iron-re-
sponsive element (IRE) in the 5′-UTR of the H- and L-
subunit mRNAs (Hentze et al. 1987; Leibold andMunro
1988; Thomson et al. 1999; Eisenstein 2000; Theil
2000). In the present study, we demonstrate a single
point mutation in the IRE region of H-subunit mRNA,
in members of a Japanese family affected with domi-
nantly inherited iron overload.
The proband, a woman aged 56 years, was admitted
to our hospital for the examination of early gastric can-
cer that was found, by chance, during a medical ex-
amination. An abdominal computed tomography (CT)
scan disclosed that the hepatic CT number had increased
to 92 units (fig. 1A), and T2-weighted magnetic reso-
nance imaging (MRI) showed low intensity signal of the
liver, heart, and bone marrow (fig. 1B). Blood exami-
nation showed a high serum ferritin level (1,654 mg/liter)
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Figure 1 Abdominal CT and MRI, showing histological features of the liver in an affected member of the family. A, CT of liver in which
the CT number increased to 92 units. B, Low-intensity signal of the liver (arrow) and heart (triangle), detected by T2-weightedMRI examination.
C, Paraffin-embedded liver biopsy specimen (top, original magnification #100) and spleen specimen (bottom, original magnification #200)
obtained from the proband, stained with Berlin’s blue (iron staining).
as well as an increase in both serum iron (156 mg/dl)
and transferrin saturation (58%) (total iron binding ca-
pacity, 269 mg/dl). Hematological examination, includ-
ing erythrocyte indices, revealed no abnormalities (red
blood cell count 4.3# 1012/liter, hemoglobin 13.3 g/dl,
and hematocrit 39%). Blood film showed no siderotic
granules (Pappenheimer bodies) in mature erythrocytes.
In a specimen obtained by needle liver biopsy, Berlin’s
staining revealed heavy iron deposition in most hepa-
tocytes and in some Kupffer cells (fig. 1C, top), sug-
gesting hemochromatosis. The iron deposition was max-
imal in hepatocytes of zones 1 and 2 of Rappaport, with
relative sparing of zone 3. Splenectomy was performed
according to a standard surgical procedure for gastric
cancer, and iron staining of the specimen also showed
gross iron deposition in macrophages (fig. 1C, bottom).
Because anemia due to chronic disease was ruled out by
(1) absence of anemia, (2) normal range of plasma C-
reactive protein and increased transferrin saturation, and
(3) a lack of history of iron supplementation, blood
transfusion, or alcohol abuse, we suspected a disease
relevant to primary hemochromatosis. We then studied
seven family members across three generations (fig. 2A)
and found that three family members (subjects II-2,
II-3, and II-4) had elevated serum ferritin levels (range
742–1,657 mg/liter). There was no history of thalas-
semia, blood transfusion or donation, abnormal dietary
iron intake, alcohol abuse, or pathological iron loss, in
any of the affected members. Furthermore, hematologic
examination revealed no abnormalities. Abdominal
MRI examination was performed on the proband’s
brother (subject II-2, aged 65 years), and both T1- and
T2-weighted MRI showed low signal intensity of the
liver and bone marrow, indicating iron deposition (re-
sults not shown). Therefore, we suspected genetic factors
as the primary cause of hemochromatosis in this family
and explored this possibility.
First, we examined the genotype associated with
genetic hemochromatosis—specifically, the HFE-1 gene
mutation (C282Y and H63D) (Feder et al. 1996) and
the TFR2 gene mutation (Y250X) (Camaschella et al,
2000)—by PCR and direct sequence analysis using DNA
purified from peripheral blood mononuclear cells. How-
ever, neither of these genotypes was detected in this fam-
ily (results not shown). Normal levels of serum copper
and ceruloplasmin activity in family members excluded
the possibility of a ceruloplasmin gene defect, which has
been shown to be associated with systemic hemosiderosis
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Figure 2 A, Pedigree of family with dominant primary iron over-
load. Blackened symbols denote individuals showing the A49T ge-
notype. The numbers under the age indicate concentrations, as follows:
1), serum ferritin (mg/l); 2), serum transferrin concentrations (mg/dl;
normal range 205–370 mg/dl). The arrow indicates the proband (II-
4). B, Sequence electropherograms and antisense sequence of H-sub-
unit IRE, shown for both a normal (Wild-type) and an affectedmember
(II-4) of the family. PCR products were elecrophoresed on 2% agarose
gel, were purified with the Qiaquick Gel Extraction Kit (Qiagen), and
were used as templates for fluorescence-based DNA sequence analysis.
The mutation is an ArT substitution at position 49, present in the
heterozygous state. C, Predicted secondary structure of the IRE motif
in the 5′ noncoding region of the H-subunit mRNA. The numbering
of bases is from the transcription start site of the human ferritin H
chain mRNA (Hentze et al. 1986). The mutation affects the second
base of the IRE loop (A49U).
(Yoshida et al. 1995). Normal levels of serum transferrin
(212 mg/dl) and an absence of microcytic anemia also
excluded atransferrinemia.
Next, we performed sequencing analysis of H- and L-
ferritin cDNAs. Total RNA was extracted from the liver
biopsy specimen and was reverse transcribed through
use of oligo-dT primer. The entire cDNA sequence of
the L and H subunits was amplified by PCR through
use of specific primers. Primer sequences were obtained
from the Entrez Nucleotide Sequence Search Web site:
5′-GTTGTTGCTTATGATGTGTGA-3′ (forward) and
5′-GTCGTGCTTGAGAGTGAGCCTT-3′ (reverse), for
L-subunit; and 5′-CCAGACGTTCTTCGCCGAGA-3′
(forward) and 5′-GCTTTCATTATCACTGTCTC-3′ (re-
verse), for H-subunit. Amplified DNA fragments were
purified and subjected to fluorescence-based DNA se-
quence analysis. Although the sequence of L-subunit
mRNA was normal, we found a heterozygous single
ArU conversion at position 49 (A49U) in the second
residue of the five-base IRE loop sequence (CAGUG) of
the H-subunit mRNA (fig. 2B and C) in four of the
family members, suggesting that this mutation was in-
herited in an autosomal dominant manner (fig. 2A). To
search for an A49T mutation in the genomic DNA, we
conducted PCR-RFLP analysis using a MunI digestion
site that recognizes a mutant IRE sequence (CAATTG)
at position 49. However, no A49T mutation was de-
tected in the genomic DNA of 42 unrelated normal sub-
jects. Three of four family members with the A49T ge-
notype had elevated serum ferritin levels. Despite having
the A49T genotype, the proband’s relatively young
daughter (III-1, aged 28 years) showed apparently nor-
mal serum ferritin. However, since she had just given
birth and was breast feeding at the time of our exam-
ination, she was likely to exhibit an increased level of
physiological iron loss. In our study, analysis of her case
of this inherited disorder leads to the conclusion that
iron accumulation may also depend on factors such as
iron intake, iron loss, and/or age.
Since IRP has been shown to interact with IRE (Haile
et al. 1989; Jaffrey et al. 1993), we performed a com-
petitive binding assay by incubation of IRP from K562
cells with either a [32P]-labeled wild-type IRE probe in
the presence of cold wild-type IRE or an A49U-mutated
IRE probe. Labeled RNAs were transcribed, in vitro,
from an oligonucleotide template, by use of T7 RNA
polymerase. The oligonucleotide used to synthesize both
the normal IRE probe and the A49U mutated IRE probe
for H subunit was as follows: 5′-TTCCGTCCAAGCAC-
TGTTGAAGCAGGAAATCGCCCTATAGTGAGTCG-
TATTA-3′. The sequence of the oligonucleotide used to
synthesize the mutated IRE probe differed by a substi-
tution of A for T in position 49. The underlined sequence
represents the T7 RNA polymerase promoter and was
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Figure 3 Band-shift assay and Scatchard-plot analysis for IRP/
IRE interaction. A, Band-shift assay for IRP and either wild-type or
mutated IRE. A [32P]-labeled wild-type IRE probe was incubated with
5 mg K562 cytoplasmic extract in the presence of either a cold wild-
type IRE probe (lanes 2–4) or a cold mutated IRE probe (lanes 5–7),
as a competitor. The IRE-IRP complexes were detected by electro-
phoresis on nondenaturing 6% polyacrylamide gels and by autora-
diography. B, Scatchard-plot analysis for IRP/IRE interaction. Five
micrograms of the cytoplasmic extract of K562 cells were incubated
with either a [32P]-labeled wild-type IRE probe or a [32P]-labeled mu-
tated probe, in the presence of heparin. Quantification of bound and
free RNA was performed by autoradiography on Kodak X-AR film
and a densitometry Fast Scan Personal Scanning Imager (Molecular
Dynamics). Data were analyzed by the LIGAND program package
and fitted to one- or two-binding-sitemodels. The dissociationconstant
(i.e., Kd) for the high-affinity binding site was calculated.
double stranded in the transcription reaction, with an
oligonucleotide complementary to this region. The RNA
used as a probe was labeled with [32P]-UTP to a specific
activity of ∼106 cpm/ng. The IRE-[32P]-IRP complex was
analyzed by electrophoresis on nondenaturing polyacryl-
amide gels. The intensity of bands for the IRP-IRE com-
plex diminished more noticeably in the presence of mu-
tated IRE probe than in the presence of wild-type IRE
probe (fig. 3A). To evaluate binding affinity between IRE
and IRP, we performed direct binding studies using a
[32P]-labeled wild-type IRE probe and a [32P]-labeled
A49U mutated IRE probe. A Scatchard plot constructed
on the basis of these results demonstrated that the
mutated IRE showed higher binding affinity to IRP
( pM) than did the wild-type IRE (K p 13.6 K p 30d d
pM), suggesting that the mutated IRE binds to IRP
rather strongly and thereby causes suppression of H-
subunit mRNA translation (fig. 3B).
We then constructed two types of FLAG-tagged H-
subunit expression vectors, one with mutated IRE and
another with wild-type IRE, to examine the effect of the
mutated H-subunit expression on the endogenous L-sub-
unit synthesis. C-terminal FLAG-tagged H-subunit ex-
pression vector (pFHFr-wt) was constructed by PCR-
based subcloning of fragments into pFLAG-CMV-5a.
The A49Tmutated H-subunit expression vector (pFHFr-
mut) was constructed by the cassette mutagenesis
method, as described elsewhere (Kawanishi et al. 1995).
COS-1 cells were transfected with 1 mg plasmid DNA
in the presence of lipofectamine, were lysed 48 h after
transfection, and were subjected to immunoblottingwith
murine anti–L-subunit polyclonal antibodies (M3) or
anti–H-subunit monoclonal antibody (HS-59) (Ruggeri
et al. 1992). Immunoblots revealed that, in the mutated
H-subunit–transfected COS-1 cells, expression of H sub-
unit was suppressed and that of endogenous L subunit
was increased in comparison to the wild-typeH-subunit
transfectant (fig. 4A). When we conducted subunit-spe-
cific immunoblotting analysis for liver ferritin, using a
patient’s (II-4) liver biopsy specimen, expression of H
subunit decreased while that of L subunit increased, as
compared with expression in normal liver (fig. 4B), con-
sistent with the results of COS-1 transfectants. These
results suggest that the A49U mutation of H subunit
would affect not only its own translation but also that
of L subunit. Since ferritin IREs are known to bind to
IRP more effectively than do mRNA IREs such as ery-
throid 5-aminolevulinic acid and transferrin receptor
(Henderson et al. 1994), the increase in L subunit may
be due to the preferential uptake of IRP by mutated H-
subunit mRNA, allowing high translation efficacy of L
subunit.
The CAGUG loop structure in the IRE is well con-
served in all ferritin mRNAs examined in vertebrates
(Aziz and Munro 1987). In vitro studies using synthetic
IRE-analogue oligonucleotides have demonstrated that
the CAGUG sequence in the loop, as well as base pairing
along the upper stem, are crucial for IRE/IRP interaction
(Jaffrey et al. 1993; Henderson et al. 1994), and sub-
stitution or deletion of a single base of IRE (especially
in the loop sequence) results in a substantial decrease in
binding affinity (6–654-fold) (Jaffrey et al. 1993). These
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Figure 4 A, Effect of mutated H-subunit transfection on expression of endogenous L subunit. A 1-mg plasmid of FLAG-tagged H-subunit
expression vector (pFHFr-wt or pFHFr-mut) was transfected to COS-1 cells by use of lipofectamine (Gibco-BRL). Cells were lysed in radioim-
munoprecipitation (RIPA) buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS) 48 h after
transfection, and protein concentration was determined by bicinchoninic-acid assay (Pierce). Ten micrograms of the extract was separated by
15%–25% SDS-PAGE, were transferred to Immobilon-P membranes (Millipore), and were probed with murine anti–L-subunit polyclonal
antibodies (M3) or anti–H-subunit monoclonal antibody (HS-59). Antibody-binding sites were detected by the ECL system (Amersham), using
horseradish-peroxidase–conjugated goat anti-mouse Ig. B, Subunit-specific immunoblot analysis of liver ferritin in an affected family member
(II-4). A portion of the liver specimen was homogenized in RIPA buffer. After centrifugation, 10 mg of the extract from either the patient’s liver
or a normal liver was subjected to 15%–25% SDS-PAGE and to immunoblotting analysis using anti–H/L-subunit antibodies. C, Effect of
mutated H-subunit expression on cellular iron uptake in COS-1 cells. COS-1 transfectants were incubated with 50 mmol/liter [59Fe]Cl3, for 6
h. Cells were lysed with 1% Triton X-100, 10 mmol Tris-HCl/liter, 150 mmol NaCl/liter, pH 7.4. The cell extract was clarified by centrifugation
at 1,000 g for 5 min, to remove debris. Cytosolic ferritin was then immunoprecipitated using anti-FLAG antibody-immobilized agarose beads.
Total cellular 59Fe uptake and 59Fe incorporation into ferritin molecules were determined by gamma counting. Error bars represent the mean
 SD of three determinations.
results from in vitro data are clinically supported by
recent studies of hereditary hyperferritinemia-cataract
syndrome (HHCS), in which point mutations in the loop
or bulge of the IRE of L-subunit mRNA resulted in a
loss of IRE affinity to IRP and in enhanced translation
of L subunit, neither of which were related to iron over-
load (Beaumont et al. 1995; Cazzola et al. 1997; Levi
et al. 1998). Our study is the first demonstration of an
increment in IRE affinity to IRP caused by a point mu-
tation at position 49 of H-subunit mRNA.
With regard to tissue iron deposition in affected in-
dividuals, we postulated that the decrease in H subunit
might be responsible, since H subunit is known to gen-
erate a ferroxidase activity that is essential for the in-
corporation of iron into the ferritin molecule (Harrison
and Arosio 1996). To test this assumption, we performed
an iron-uptake assay using the aforementioned COS-1
transfectants. After transient expression of the mutated
H subunit or wild-type H subunit in COS-1 cells,
[59Fe]Cl3 was added to the culture medium. The cells
were solubilized, and cytosolic ferritin was immunopre-
cipitated through use of anti-FLAG antibody. In the mu-
tated H-ferritin transfectant, 59Fe incorporation into the
ferritin molecule was significantly lower and total cel-
lular uptake of iron was higher than they were in the
wild-type H-ferritin transfectant (fig. 4C). This result
suggested that the decrease in H subunit not only im-
paired iron uptake into the ferritin molecule but also
caused iron accumulation in the cytosol, possibly be-
cause of the decrease in ferroxidase activity. This as-
sumption has been verified by a recent study (Ferreira
et al. 2000), in which H-ferritin gene–knockout mice
showed early embryonic lethality due to massive iron
deposition. In this respect, it is of interest that no iron
overload is associated with HHCS (Beaumont et al.
1995), despite L subunit being similarly increased; this
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is probably because of the fact that H subunit is not
affected. Furthermore, the effect of the mutation in the
L-subunit IRE in patients with HHSC is associated with
a relatively benign phenotype: early onset of cataracts
(Beaumont et al. 1995).
In the present study, we have characterized an A49T
mutation in the IRE sequence of the H-ferritin gene as
a novel, inherited genetic abnormality related to iron
overload. Since the H-ferritin gene and genes for IRE-
binding proteins have been reported to be unrelated to
chromosome 6p (the locus for HFE hemochromatosis)
(Zheng et al. 1994), this genotype may be associated
with non-HFE-type iron overload. In this regard, it may
be noteworthy that autosomal dominant and non-HFE-
type iron overload has been reported elsewhere, in three
Japanese families (Kawanaka et al. 1998). Additional
family studies are certainly needed to elucidate whether
this mutation is an isolated or a common one.
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